Pharma Journalist - Page 107 of 834 -

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia

FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application

Amgen’s IMDYLLTRA Granted Conditional Approval for Small Cell Lung Cancer in UK

Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture

Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease

Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE

Fresenius Kabi receives U.S. FDA approval for biosimilar Idacio (adalimumab)

UCB and Praxis Precision Medicines Announce Epilepsy Research Collaboration

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

European Commission approves SPEVIGO (spesolimab) for generalized pustular psoriasis flares

Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics

GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets

Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications